With weight loss programming, mental health management, sexual health support, and products for hair and skin, Hers makes it easy to get prescriptions delivered to your door
How It Works Ozempic functions by mimicking the endogenous GLP-1 hormone, which plays a documented role in blood sugar regulation through several mechanisms observed in clinical research subjects: Appetite modulation: Research indicates that GLP-1 receptor activation influences satiety signalling, reducing overall caloric intake in studied populations Insulin secretion: The compound stimulates glucose-dependent insulin release from pancreatic beta cells in response to food intake, contributing to improved glycemic control Gastric motility: Clinical literature documents a slowing of gastric emptying, which has been associated with reduced post-prandial blood glucose elevation in research subjects Key Research Insights Studied for its role in maintaining stable glucose levels in Type 2 diabetes populations across clinical trials Investigated for cardiovascular risk reduction, with documented evidence of decreased incidence of serious cardiovascular events including myocardial infarction and stroke Examined for its once-weekly pharmacokinetic profile, supporting consistent administration and protocol adherence Researched for its secondary influence on body weight parameters through appetite and metabolic pathway modulation Product Overview Developed by Novo Nordisk, a globally recognized pharmaceutical manufacturer specializing in metabolic and endocrine compounds Contains semaglutide, a well-documented GLP-1 receptor agonist with an established clinical evidence base Pre-filled pen format designed for once-weekly subcutaneous self-administration Approved compound with documented cardiovascular and glycemic endpoints across large-scale clinical trials Ozempic 1mg Semaglutide Pen Prepare the Pen: Attach a new needle and remove the cap
It is typically considered for people with a BMI of 40 or higher or those with a BMI of 35 or higher who have obesity-related health problems
Some studies have shown promise in improving sperm concentration and motility in men with idiopathic infertility, though evidence for effects on pregnancy rates remains limited
